According to Mirati Therapeutics's latest financial reports the company's total assets are $1.12 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $1.20 B | -24.3% |
2021-12-31 | $1.58 B | 7.63% |
2020-12-31 | $1.47 B | 241.54% |
2019-12-31 | $0.43 B | 89.18% |
2018-12-31 | $0.22 B | 45.28% |
2017-12-31 | $0.15 B | 147.85% |
2016-12-31 | $63.44 M | -50.44% |
2015-12-31 | $0.12 B | 282.38% |
2014-12-31 | $33.47 M | -48.12% |
2013-12-31 | $64.53 M | 62.15% |
2012-12-31 | $39.8 M | 28.56% |
2011-12-31 | $30.95 M | 183.79% |
2010-12-31 | $10.9 M | -48.08% |
2009-12-31 | $21.01 M | -47.09% |
2008-12-31 | $39.71 M | -46.23% |
2007-12-31 | $73.85 M | 12.29% |
2006-12-31 | $65.77 M | 118.35% |
2005-12-31 | $30.12 M | -26.85% |
2004-12-31 | $41.17 M | 25.93% |
2003-12-31 | $32.69 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
TravelCenters of America TA | $3.57 B | 216.65% | ๐บ๐ธ USA |
Nymox Pharmaceutical NYMX | $0.27 M | -99.98% | Bahamas |